James Clemmer | executive |
Stephen Trowbridge | executive |
John Young | analyst |
Steven Lichtman | analyst |
Yi Chen | analyst |
Good morning, and welcome to the AngioDynamics Fiscal Year 2024 Fourth Quarter Earnings Call. [Operator Instructions] As a reminder, this conference call is being recorded. The news release detailing AngioDynamics Fiscal 2024 Fourth Quarter and Full Year Results crossed the wire earlier this morning and is available on the company's website. This conference call is also being broadcast live over the Internet at the Investors section of the company's website at www.angiodynamics.com, and the webcast replay of the call will be available at the same site approximately one hour after the end of today's call.
Before we begin, I would like to caution listeners that during the course of this conference call, the company will make projections or forward-looking statements regarding future events, including statements about expected revenue, adjusted earnings and gross margins for fiscal year 2025 as well as trends that may continue.